Brain Aging and Dementia

See this COE's new website.  

The Center of Excellence on Brain Aging and Dementia will provide “one-stop” multi-disciplinary evaluation and clinical care in the early diagnosis, treatment and prevention of Alzheimer’s disease and other neurodegenerative disorders affecting cognition.

This disease affects more than five million Americans, a number expected to more than triple to 16 million by 2050. It costs society an estimated $150 billion in the United States alone because of the enormous burden of care for family members and caregivers. NYU scientists broke ground in the fight against these diseases by being among the first to characterize the plaque-forming protein implicated in Alzheimers’s.

The scientists and clinicians at this Center will study the fundamental disease processes in animal models and humans, with the goal of developing new diagnostic tools and therapies and to explore new psychosocial interventions for patients and caregivers.

Director:
Ralph Nixon, M.D., Ph.D., Professor of Psychiatry and Cell Biology / Vice Chairman of Research, Department of Psychiatry / Director of Silberstein Institute for Aging and Dementia
View list of participants here